IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q4 2022 Holdings

Filed 2023-02-14 | 29 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$195.2M1,885,81116.6%
United Therapeutics Corp(UTHR)COM91307C102$173.9M625,41414.8%
Amicus Therapeutics Inc(FOLD)COM03152W109$128.1M10,493,72210.9%
Insmed Inc(INSM)COM457669307$117.3M5,871,29110.0%
Biogen Inc(BIIB)COM09062X103$105.3M380,0829.0%
Prothena Corp PLC(PRTA)COMG72800108$99.9M1,658,5778.5%
Revance Therapeutics Inc(RVNCEUR)COM761330109$97.5M5,283,6098.3%
Staar Surgical Co(STAA)COM852312305$60.2M1,240,0775.1%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$37.8M2,376,3693.2%
Sage Therapeutics Inc(SG7)COM78667J108$32.7M856,5172.8%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$19.2M5,655,6761.6%
Alkermes PLC(ALKS)COMG01767105$15.8M603,4001.3%
Align Technology Inc(ALGN)COM016255101$15.7M74,6051.3%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$15.6M612,6001.3%
Anaptysbio Inc(ANAB)COM032724106$13.4M431,0241.1%
Ehealth Inc(EHTH)COM28238P109$12.0M2,484,4791.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$8.0M1,087,6070.7%
Cytokinetics Inc(CYTK)COM23282W605$5.1M111,7170.4%
Kezar Life Sciences IncCOM49372L100$4.6M656,2000.4%
Provention BIO Inc(PRVBUSD)COM74374N102$4.1M390,8000.4%
Travere Therapeutics Inc(TVTX)COM89422G107$3.5M166,0690.3%
Gritstone Oncology Inc(2JQ)COM39868T105$2.3M666,1270.2%
Peak BIO IncCOM70470P108$2.0M497,5280.2%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$1.3M64,7000.1%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.1M160,8000.1%
Alimera Sciences IncCOM016259202$544.5K200,9190.0%
Tactile Systems Technology I(TCMD)COM87357P100$311.1K27,1000.0%
Urogen Pharma LTD(URGN)COMM96088105$217.3K24,5000.0%
Gossamer BIO Inc(GOSS)COM38341P102$81.9K37,7500.0%